vs

Side-by-side financial comparison of GREAT SOUTHERN BANCORP, INC. (GSBC) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $56.4M, roughly 1.5× GREAT SOUTHERN BANCORP, INC.). GREAT SOUTHERN BANCORP, INC. runs the higher net margin — 28.9% vs -38.1%, a 66.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -0.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 4.5%).

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GSBC vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.5× larger
PRCT
$83.1M
$56.4M
GSBC
Growing faster (revenue YoY)
PRCT
PRCT
+20.4% gap
PRCT
20.2%
-0.2%
GSBC
Higher net margin
GSBC
GSBC
66.9% more per $
GSBC
28.9%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
4.5%
GSBC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GSBC
GSBC
PRCT
PRCT
Revenue
$56.4M
$83.1M
Net Profit
$16.3M
$-31.6M
Gross Margin
64.9%
Operating Margin
34.5%
-4.1%
Net Margin
28.9%
-38.1%
Revenue YoY
-0.2%
20.2%
Net Profit YoY
9.1%
-27.9%
EPS (diluted)
$1.44
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GSBC
GSBC
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$56.4M
$76.4M
Q3 25
$57.8M
$83.3M
Q2 25
$59.2M
$79.2M
Q1 25
$55.9M
$69.2M
Q4 24
$56.5M
$68.2M
Q3 24
$55.0M
$58.4M
Q2 24
$56.7M
$53.4M
Net Profit
GSBC
GSBC
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$16.3M
$-29.8M
Q3 25
$17.8M
$-21.4M
Q2 25
$19.8M
$-19.6M
Q1 25
$17.2M
$-24.7M
Q4 24
$14.9M
$-18.9M
Q3 24
$16.5M
$-21.0M
Q2 24
$17.0M
$-25.6M
Gross Margin
GSBC
GSBC
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
GSBC
GSBC
PRCT
PRCT
Q1 26
-4.1%
Q4 25
34.5%
-40.6%
Q3 25
38.2%
-27.8%
Q2 25
41.0%
-28.0%
Q1 25
38.4%
-39.7%
Q4 24
31.8%
-28.9%
Q3 24
36.6%
-38.4%
Q2 24
36.8%
-50.3%
Net Margin
GSBC
GSBC
PRCT
PRCT
Q1 26
-38.1%
Q4 25
28.9%
-39.1%
Q3 25
30.7%
-25.7%
Q2 25
33.4%
-24.7%
Q1 25
30.7%
-35.8%
Q4 24
26.4%
-27.6%
Q3 24
30.0%
-35.9%
Q2 24
30.0%
-48.0%
EPS (diluted)
GSBC
GSBC
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$1.44
$-0.54
Q3 25
$1.56
$-0.38
Q2 25
$1.72
$-0.35
Q1 25
$1.47
$-0.45
Q4 24
$1.27
$-0.34
Q3 24
$1.41
$-0.40
Q2 24
$1.45
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GSBC
GSBC
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$189.6M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$636.1M
$347.7M
Total Assets
$5.6B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GSBC
GSBC
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$189.6M
$286.5M
Q3 25
$196.2M
$294.3M
Q2 25
$245.9M
$302.7M
Q1 25
$217.2M
$316.2M
Q4 24
$195.8M
$333.7M
Q3 24
$208.4M
$196.8M
Q2 24
$186.5M
$214.1M
Total Debt
GSBC
GSBC
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
GSBC
GSBC
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$636.1M
$365.9M
Q3 25
$632.9M
$380.3M
Q2 25
$622.4M
$385.8M
Q1 25
$613.3M
$389.2M
Q4 24
$599.6M
$402.2M
Q3 24
$612.1M
$241.2M
Q2 24
$568.8M
$251.8M
Total Assets
GSBC
GSBC
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$5.6B
$508.1M
Q3 25
$5.7B
$511.5M
Q2 25
$5.9B
$513.1M
Q1 25
$6.0B
$519.4M
Q4 24
$6.0B
$534.0M
Q3 24
$6.0B
$374.1M
Q2 24
$6.0B
$374.4M
Debt / Equity
GSBC
GSBC
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GSBC
GSBC
PRCT
PRCT
Operating Cash FlowLast quarter
$81.5M
Free Cash FlowOCF − Capex
$70.1M
FCF MarginFCF / Revenue
124.3%
Capex IntensityCapex / Revenue
20.3%
Cash ConversionOCF / Net Profit
5.01×
TTM Free Cash FlowTrailing 4 quarters
$121.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GSBC
GSBC
PRCT
PRCT
Q1 26
Q4 25
$81.5M
$-10.3M
Q3 25
$5.6M
$-6.6M
Q2 25
$39.3M
$-15.0M
Q1 25
$15.0M
$-17.0M
Q4 24
$44.1M
$-32.4M
Q3 24
$17.7M
$-18.8M
Q2 24
$43.5M
$-15.7M
Free Cash Flow
GSBC
GSBC
PRCT
PRCT
Q1 26
Q4 25
$70.1M
$-12.2M
Q3 25
$3.9M
$-9.5M
Q2 25
$34.9M
$-17.8M
Q1 25
$13.1M
$-18.8M
Q4 24
$39.1M
$-33.6M
Q3 24
$16.5M
$-19.0M
Q2 24
$42.0M
$-16.8M
FCF Margin
GSBC
GSBC
PRCT
PRCT
Q1 26
Q4 25
124.3%
-15.9%
Q3 25
6.7%
-11.4%
Q2 25
59.0%
-22.5%
Q1 25
23.4%
-27.2%
Q4 24
69.3%
-49.2%
Q3 24
30.1%
-32.6%
Q2 24
74.1%
-31.4%
Capex Intensity
GSBC
GSBC
PRCT
PRCT
Q1 26
Q4 25
20.3%
2.4%
Q3 25
3.0%
3.4%
Q2 25
7.4%
3.5%
Q1 25
3.5%
2.7%
Q4 24
8.7%
1.7%
Q3 24
2.1%
0.4%
Q2 24
2.7%
2.0%
Cash Conversion
GSBC
GSBC
PRCT
PRCT
Q1 26
Q4 25
5.01×
Q3 25
0.31×
Q2 25
1.99×
Q1 25
0.87×
Q4 24
2.95×
Q3 24
1.07×
Q2 24
2.56×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GSBC
GSBC

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons